ATE233269T1 - Regioselektive synthese von rapamycinderivaten - Google Patents

Regioselektive synthese von rapamycinderivaten

Info

Publication number
ATE233269T1
ATE233269T1 AT00966904T AT00966904T ATE233269T1 AT E233269 T1 ATE233269 T1 AT E233269T1 AT 00966904 T AT00966904 T AT 00966904T AT 00966904 T AT00966904 T AT 00966904T AT E233269 T1 ATE233269 T1 AT E233269T1
Authority
AT
Austria
Prior art keywords
regioselevant
synthesis
rapamycin derivatives
rapamycin
derivatives
Prior art date
Application number
AT00966904T
Other languages
English (en)
Inventor
Chia-Cheng Shaw
John Hamilton Sellstedt
Razzak Noureldin
Gloria Karen Cheal
Genevieve Fortier
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE233269T1 publication Critical patent/ATE233269T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00966904T 1999-09-29 2000-09-27 Regioselektive synthese von rapamycinderivaten ATE233269T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40883099A 1999-09-29 1999-09-29
PCT/US2000/026445 WO2001023395A2 (en) 1999-09-29 2000-09-27 Regioselective synthesis of rapamycin derivatives

Publications (1)

Publication Number Publication Date
ATE233269T1 true ATE233269T1 (de) 2003-03-15

Family

ID=23617953

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00966904T ATE233269T1 (de) 1999-09-29 2000-09-27 Regioselektive synthese von rapamycinderivaten

Country Status (24)

Country Link
EP (1) EP1216251B1 (de)
JP (1) JP4289813B2 (de)
KR (1) KR100754236B1 (de)
CN (1) CN1176925C (de)
AR (1) AR029181A1 (de)
AT (1) ATE233269T1 (de)
AU (1) AU782234B2 (de)
BR (1) BR0014433A (de)
CA (1) CA2385461C (de)
CZ (1) CZ300368B6 (de)
DE (1) DE60001510T2 (de)
DK (1) DK1216251T3 (de)
EA (1) EA004331B1 (de)
ES (1) ES2189768T3 (de)
HK (1) HK1044774B (de)
HU (1) HUP0202609A3 (de)
IL (2) IL148542A0 (de)
MX (1) MXPA02003243A (de)
NO (1) NO20021360L (de)
NZ (1) NZ517644A (de)
PL (1) PL200899B1 (de)
TW (1) TWI256395B (de)
WO (1) WO2001023395A2 (de)
ZA (1) ZA200201918B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
WO2005023254A1 (en) 2003-09-03 2005-03-17 Wyeth Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same
AR046194A1 (es) 2003-11-04 2005-11-30 Mayo Foundation Metodo de tratamiento del linfoma de celulas del manto
CA2564811A1 (en) 2004-04-14 2005-10-27 Wyeth Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase
CA2562952A1 (en) * 2004-04-14 2005-11-10 Wyeth Regiospecific synthesis of rapamycin 42-ester derivatives
AR050452A1 (es) 2004-08-10 2006-10-25 Wyeth Corp Derivados de cci-779
ZA200706804B (en) 2005-02-03 2008-10-29 Gen Hospital Corp Method for treating gefitinib resistant cancer
AU2006213061A1 (en) 2005-02-09 2006-08-17 Wyeth CCI-779 polymorph and use thereof
KR101354828B1 (ko) 2005-11-04 2014-02-18 와이어쓰 엘엘씨 ｍＴＯＲ 저해자, 헤르셉틴, 및/또는 ＨＫＩ-272의항신생물성 조합
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
CA2725598C (en) 2008-06-17 2013-10-08 Wyeth Llc Antineoplastic combinations containing hki-272 and vinorelbine
CN101676291B (zh) 2008-09-18 2012-05-09 上海海和药物研究开发有限公司 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途
EP2528906A2 (de) * 2010-01-28 2012-12-05 Fresenius Kabi Oncology Ltd Verfahren zur herstellung von temsirolimus und seinen zwischenprodukten
CN102020662B (zh) 2011-01-07 2013-02-13 天津市炜杰科技有限公司 一种驮瑞塞尔制备方法
RU2603261C2 (ru) * 2011-04-01 2016-11-27 Сандоз Аг Региоселективное ацилирование рапамицина в положении с-42
CN103421023B (zh) * 2013-07-30 2015-09-23 福建省微生物研究所 一种替西罗莫司的合成工艺
CN104086564B (zh) * 2014-07-30 2019-02-05 江苏奥赛康药业股份有限公司 一种高纯度坦罗莫司的制备方法
CN106146536B (zh) * 2015-04-25 2019-07-26 山东新时代药业有限公司 一种依维莫司的制备方法
US10456477B2 (en) * 2016-03-14 2019-10-29 Wisconsin Alumni Research Foundation Oligolactic acid conjugates and micelles with enhanced anticancer efficacy
CN107561170B (zh) * 2016-07-02 2021-07-30 山东新时代药业有限公司 一种坦西莫司中间体的分析检测方法
CN108948045A (zh) * 2017-05-20 2018-12-07 鲁南制药集团股份有限公司 一种替西罗莫司的制备方法
CN108948046B (zh) * 2017-05-20 2020-11-10 鲁南制药集团股份有限公司 一种替西罗莫司的中间体及其制备方法
CN109206441B (zh) * 2017-06-30 2022-05-20 正大天晴药业集团股份有限公司 一种依维莫司的纯化方法
CN109776570A (zh) * 2017-11-14 2019-05-21 上海医药工业研究院 一种依维莫司中间体、其制备方法及其应用
BR112020025283A2 (pt) 2018-06-15 2021-03-09 Navitor Pharmaceuticals, Inc. Análogos de rapamicina e usos dos mesmos
CN109369679A (zh) * 2018-12-24 2019-02-22 江苏卓和药业有限公司 一种雷帕霉素的精制方法
CN109851626B (zh) * 2019-01-08 2021-11-02 扬子江药业集团四川海蓉药业有限公司 一种替西罗莫司的分离纯化方法
AU2020397938A1 (en) 2019-12-05 2022-06-23 Janssen Pharmaceutica Nv Rapamycin analogs and uses thereof
CN113372359A (zh) * 2020-03-10 2021-09-10 鲁南制药集团股份有限公司 一种坦西莫司的制备方法
CN114106014B (zh) * 2020-08-27 2024-03-15 鲁南制药集团股份有限公司 一种依维莫司的制备方法
CN115028658A (zh) * 2022-07-06 2022-09-09 国药集团川抗制药有限公司 雷帕霉素硅醇酯及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120842A (en) * 1991-04-01 1992-06-09 American Home Products Corporation Silyl ethers of rapamycin
US5387680A (en) * 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines

Also Published As

Publication number Publication date
HK1044774A1 (en) 2002-11-01
EP1216251A2 (de) 2002-06-26
DK1216251T3 (da) 2003-06-16
NO20021360D0 (no) 2002-03-19
CN1402731A (zh) 2003-03-12
NO20021360L (no) 2002-03-19
HK1044774B (en) 2003-05-30
WO2001023395A3 (en) 2001-10-25
JP2003510329A (ja) 2003-03-18
CZ20021136A3 (cs) 2002-06-12
CA2385461A1 (en) 2001-04-05
ZA200201918B (en) 2003-08-27
CA2385461C (en) 2009-03-17
MXPA02003243A (es) 2002-09-30
AR029181A1 (es) 2003-06-18
PL354461A1 (en) 2004-01-12
DE60001510D1 (de) 2003-04-03
NZ517644A (en) 2003-09-26
IL148542A0 (en) 2002-09-12
TWI256395B (en) 2006-06-11
IL148542A (en) 2006-08-20
AU782234B2 (en) 2005-07-14
HUP0202609A2 (hu) 2002-12-28
AU7718200A (en) 2001-04-30
JP4289813B2 (ja) 2009-07-01
EA004331B1 (ru) 2004-04-29
EA200200412A1 (ru) 2002-10-31
DE60001510T2 (de) 2003-10-02
CZ300368B6 (cs) 2009-05-06
KR100754236B1 (ko) 2007-09-03
HUP0202609A3 (en) 2004-11-29
BR0014433A (pt) 2002-06-11
KR20020029796A (ko) 2002-04-19
PL200899B1 (pl) 2009-02-27
WO2001023395A2 (en) 2001-04-05
CN1176925C (zh) 2004-11-24
EP1216251B1 (de) 2003-02-26
ES2189768T3 (es) 2003-07-16

Similar Documents

Publication Publication Date Title
ATE233269T1 (de) Regioselektive synthese von rapamycinderivaten
DE69916582D1 (de) Synthese von zsm-48
FR15C0096I2 (fr) Derives carbamoyloxyalkyl-azolium n-substitues
DE69924930D1 (de) Synthese von Oligonukleotiden
EP1181293A4 (de) Cucurbiturile und verfahren zu ihrer herstellung
AR028567A1 (es) Nuevos derivados de fenil-propargileter
NO20021077L (no) Amino-triazolopyridin-derivater
NO20013945L (no) Fremstilling av isoflavonderivater
ATE263748T1 (de) Admantan-derivate
AR028596A1 (es) Nuevos derivados de fenilglicina
ATE242750T1 (de) Synthese von kristallinen silicoaluminophosphaten
ATE270270T1 (de) Neuartige phenylalkyloxy-phenyl-derivate
DK1202953T3 (da) Substituerede 2-dialkylaminoalkylbiphenylderivater
DE69912206D1 (de) Verbesserte Synthese von Haloformiminverbindungen
DE59902179D1 (de) Elektrochemische synthese von perfluoralkylfluorophosphoranen
ATE257148T1 (de) Propargyletherderivate
DE60313173D1 (de) Synthese von purin-derivaten
PT1246817E (pt) Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo
ATE217308T1 (de) Chemische synthese von morpholinderivaten
ATE231865T1 (de) Imidazodiazepinderivate
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
EE200200389A (et) Imidasooli uued derivaadid
NO20022971D0 (no) Butyndiol-derivater
NO20022682L (no) Heterosykliske derivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1216251

Country of ref document: EP

REN Ceased due to non-payment of the annual fee